PubRank

F Parent

Author PubWeight™ 55.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998 7.08
2 Epidural corticosteroid injections for sciatica due to herniated nucleus pulposus. N Engl J Med 1997 5.17
3 Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010 2.90
4 Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J 1998 2.14
5 Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax 2005 2.03
6 Primary pulmonary hypertension and fenfluramine use. Br Heart J 1993 2.02
7 High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. Chest 1999 1.70
8 Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000 1.54
9 Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Eur Respir J 2007 1.51
10 Diagnosis and management of subsegmental pulmonary embolism. J Thromb Haemost 2006 1.47
11 Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 1995 1.46
12 Long term imatinib treatment in pulmonary arterial hypertension. Thorax 2006 1.32
13 Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation 1994 1.24
14 Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000 1.23
15 Risk factors for pulmonary arterial hypertension. Clin Chest Med 2001 1.20
16 Pathobiology of pulmonary hypertension. The role of platelets and thrombosis. Clin Chest Med 2001 1.11
17 Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO study. J Thromb Haemost 2007 1.09
18 Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension. Circulation 1996 1.07
19 Three-dimensional measurement of wedged scoliotic vertebrae and intervertebral disks. Eur Spine J 1998 1.01
20 Is obesity associated with injuries among young people? Eur J Epidemiol 2004 1.01
21 Morphometric evaluations of personalised 3D reconstructions and geometric models of the human spine. Med Biol Eng Comput 1997 0.98
22 [Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients]. J Mal Vasc 2010 0.96
23 Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. J Nucl Med 1997 0.91
24 Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation. J Heart Lung Transplant 1997 0.90
25 [Surgical treatment of chronic thromboembolic pulmonary hypertension]. Presse Med 2005 0.89
26 Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different. Eur Respir J 2012 0.88
27 Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma. Ann Oncol 2010 0.87
28 Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb Haemost 2014 0.87
29 Occult alveolar haemorrhage in pulmonary veno-occlusive disease. Eur Respir J 2006 0.86
30 Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy. Am J Respir Crit Care Med 2001 0.85
31 The association between resting and mild-to-moderate exercise pulmonary artery pressure. Eur Respir J 2011 0.85
32 Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study. Eur Respir J 1999 0.83
33 Discrepancies in cancer incidence and mortality and its relationship to health expenditure in the 27 European Union member states. Ann Oncol 2013 0.83
34 [Pulmonary complications in adult sickle cell disease]. Rev Mal Respir 2011 0.81
35 Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study Group. Haemostasis 1999 0.81
36 [Thrombosis and lung cancer]. Rev Pneumol Clin 2008 0.78
37 Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre. Eur Respir Rev 2009 0.78
38 Blood pressure measurement in epidemiological investigations in teenagers. Eur J Epidemiol 2001 0.77
39 [Pulmonary hypertension and obesity]. Rev Pneumol Clin 2002 0.77
40 Kinematic modeling for the assessment of wheelchair user's stability. IEEE Trans Neural Syst Rehabil Eng 2001 0.76
41 [Pulmonary arterial hypertension due to tumor emboli]. Rev Mal Respir 2007 0.76
42 [Pulmonary hypertension complicating systemic diseases other than connective tissue diseases]. Presse Med 2003 0.75
43 [Pulmonary thromboendarterectomy with video-angioscopy and circulatory arrest: an alternative to cardiopulmonary transplantation and post-embolism pulmonary artery hypertension]. Chirurgie 1998 0.75
44 [Venous thromboembolism]. Rev Mal Respir 2005 0.75
45 [Multiple free transplants in microsurgery for cervicofacial reconstruction]. Chirurgie 1996 0.75
46 [A report on the 4th International Forum of Medical Education]. Rev Med Brux 2007 0.75
47 [Value of videostroboscopy in indicating phonosurgery]. Acta Otorhinolaryngol Belg 1986 0.75
48 [Postembolic pulmonary hypertension]. Rev Mal Respir 2007 0.75
49 [Complete reconstruction of the nose using a prefabricated free forearm graft]. Chirurgie 1994 0.75
50 [Chronic pulmonary heart disease: therapeutic indications]. Arch Mal Coeur Vaiss 1995 0.75
51 [Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial]. Rev Mal Respir 2008 0.75
52 [Antithrombotic therapy for venous thromboembolism - report of the 7th Conference of The American College of Chest Physicians]. Rev Mal Respir 2005 0.75
53 [Post-embolic pulmonary arterial hypertension: therapeutic indications]. Cardiologia 1995 0.75
54 [Pulmonary embolism: the extent of computerized tomography]. Rev Pneumol Clin 2008 0.75
55 A process of change in first-line health services in Chad. Health Policy Plan 2001 0.75
56 [Pulmonary arterial hypertension of chronic thromboembolic origin; therapeutic indications]. Arch Mal Coeur Vaiss 1994 0.75
57 Recombinant hirudin (HBW 023): biological data of ten patients with severe venous thrombo-embolism. Am J Hematol 1995 0.75
58 Recurrent thromboembolism in two unrelated patients with double heterozygosity for factor V R506Q and factor II 20210G/A mutations. Thromb Haemost 1998 0.75
59 [Multiple free transplants in reconstructive surgery]. Presse Med 1995 0.75
60 [Seventeenth century French universities and health science education]. Rev Med Brux 2008 0.75
61 [Surgical treatment of post-embolism pulmonary hypertension]. Rev Pneumol Clin 2004 0.75
62 Vitamin K metabolism in a patient resistant to vitamin K antagonists. Haemostasis 1998 0.75